NN, Inc., a diversified industrial manufacturer, combines in-depth materials science expertise with advanced engineering and production capabilities to design and manufacture a broad range of high-precision metal and plastic components and assemblies. The company serves a variety of attractive end markets on a global basis, including transportation, aerospace and defense, general industrial, electrical, medical and more. As a globally diverse company with more than 1,500 customers, NN expects 2016 revenues of $890M. NN employees 5,400 people and has 42 manufacturing facilities with locations in North America, South America, Europe and China.
Company Growth (employees)
Johnson City, US
Size (employees)
4,730 (est)
NN was founded in 1980 and is headquartered in Johnson City, US

NN Office Locations

NN has an office in Johnson City
Johnson City, US (HQ)
207 Mockingbird Ln

NN Financials and Metrics

NN Financials

NN's revenue was reported to be $226.3 m in Q1, 2017

Revenue (Q1, 2017)

226.3 m

Gross profit (Q1, 2017)

59.4 m

Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)

7.4 m

EBIT (Q1, 2017)

22.2 m

Market capitalization (16-Oct-2017)

832.3 m

Cash (31-Mar-2017)

19.6 m
NN's current market capitalization is $832.3 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


373.2 m488.6 m667.3 m833.5 m

Revenue growth, %


Cost of goods sold

526 m621 m

Gross profit

141.3 m212.5 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


106.7 m125.6 m163.7 m164.9 m154.8 m212.2 m214.3 m205 m226.3 m

Cost of goods sold

84.3 m100.4 m129.3 m128.7 m120.2 m159.8 m156.8 m152.5 m167 m

Gross profit

22.4 m25.2 m34.4 m36.1 m34.6 m52.5 m57.5 m52.4 m59.4 m

Gross profit Margin, %

USDY, 2009Y, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016


8.7 m5.6 m4.5 m19 m3 m37.3 m15.1 m14.4 m

Accounts Receivable

58.9 m97.5 m123 m139.5 m


54.5 m91.5 m119.8 m114.9 m

Current Assets

125.7 m242.8 m280.2 m280.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


5.8 m26.9 m16.8 m21.4 m40.1 m15.1 m15.1 m14.8 m19.6 m

Accounts Receivable

117.2 m114.8 m108.1 m143.3 m147.1 m147.4 m159.6 m


61.5 m86.9 m85.6 m87.9 m92.6 m120.1 m118.8 m118.8 m116.6 m

Current Assets

158 m246.7 m238 m240.7 m258.4 m295.6 m297.9 m295.5 m310.3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

17.2 m8.2 m(7.4 m)7.9 m

Depreciation and Amortization

17 m22.1 m44.5 m62.5 m

Accounts Receivable

(6.3 m)(3.3 m)(806 k)(18.5 m)


(7.2 m)(9.8 m)(1.8 m)4.4 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

5.2 m(3.8 m)6 m7 m4.6 m(1.3 m)2 m4.1 m7.4 m

Depreciation and Amortization

4.1 m5.9 m8.5 m8.6 m8.6 m17.3 m15.1 m14.7 m15.6 m

Accounts Receivable

114.8 m108.1 m143.3 m147.1 m147.4 m159.6 m


87.9 m92.6 m120.1 m118.8 m118.8 m116.6 m
USDY, 2017


47.8 k

Financial Leverage

4.2 x
Show all financial metrics

NN Market Value History

Traffic Overview of NN

NN Online and Social Media Presence

NN News and Updates

Parcom Capital buys Viroclinics

Parcom Capital said Aug. 29 that it has acquired Viroclinics Biosciences. Financial terms weren’t announced. Viroclinics, of the Netherlands, tests new vaccines and drugs in the clinical trial stages prior to their market launch.

NN Company Life and Culture

You may also be interested in